Text Size

The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.

This study has been completed.
Sponsor:
Collaborator:
Saskatoon Health Region
Information provided by:
University of Saskatchewan
ClinicalTrials.gov Identifier:
NCT00230425
First received: September 27, 2005
Last updated: October 10, 2006
Last verified: September 2005
History of Changes
  Purpose

The purpose of this study is to measure daily mood changes and to find out whether these mood changes are related to the ability to maintain attention on a task. Problems with mood are more common among women however, the association between symptoms of alcohol abuse and mood syndromes is inconsistent.

First we hypothesize that women with lifetime diagnoses of alcohol abuse will not demonstrate higher symptoms of anxiety, depression, neuroticism and mood variability than control groups. Second, that the severity of these symptoms will not correlate with performance on measures of sustained attention.


Condition
Alcohol Abuse
Anxiety Disorders
Mood Disorders

Study Type: Observational
Study Design: Additional Descriptors: Psychosocial
Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Saskatchewan:

Estimated Enrollment: 30
Study Start Date: February 2003
Estimated Study Completion Date: June 2004
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Females ages 18 to 50.
  • Diagnosed with alcohol abuse issues.

Exclusion Criteria:

  • Males (any age).
  • Chronic medical (organic) or psychiatric conditions that might affect mood variability or test performance.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230425

Locations
Canada, Saskatchewan
Calder Centre
Saskatoon, Saskatchewan, Canada, S7J 2H6
Sponsors and Collaborators
University of Saskatchewan
Saskatoon Health Region
Investigators
Principal Investigator: Rudy Bowen, MD University of Saskatchewan
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00230425     History of Changes
Other Study ID Numbers: BSC 02-760
Study First Received: September 27, 2005
Last Updated: October 10, 2006
Health Authority: Canada: Ethics Review Committee

Keywords provided by University of Saskatchewan:
Alcohol Abuse
Anxiety Disorders
Mood Disorders

Additional relevant MeSH terms:
Alcoholism
Anxiety Disorders
Mood Disorders
 Alcohol-Related Disorders
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013